Prot #U31402-A-U201: HERTHENA-Lung01: A Phase 2 Randomized Open-Label Study of Patritumab Deruxtecan (U3-1402) in Subjects with Previously Treated Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer (NSCLC)

Project: Research project

Project Details

StatusActive
Effective start/end date4/9/21 → 4/9/27

Funding

  • INC Research, LLC ((OE) Prot #U31402-A-U201 Amend#1 // (OE) Prot #U31402-A-U201 ...)
  • Daiichi Sankyo, Inc. ((OE) Prot #U31402-A-U201 Amend#1 // (OE) Prot #U31402-A-U201 ...)